EMD-26507

Single-particle
3.9 Å
EMD-26507 Deposition: 26/03/2022
Map released: 08/06/2022
Last modified: 08/06/2022
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-26507

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

SARS-CoV-2 spike in complex with Multivalent miniprotein inhibitor FUS231-P24 (2RBDs open)

EMD-26507

Single-particle
3.9 Å
EMD-26507 Deposition: 26/03/2022
Map released: 08/06/2022
Last modified: 08/06/2022
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Sample: SARS-CoV-2 spike in complex with multivalent minibinder FUS231-P24 (2RBDs open)

Deposition Authors: Park YJ , Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice.
PUBMED: 35412328
DOI: doi:10.1126/scitranslmed.abn1252
ISSN: 1946-6242